September 7, 2012 — Elevated rheumatoid factor (RF) levels in healthy patients may be a strong predictor of future rheumatoid arthritis (RA), according to data from a prospective cohort study ...

Antibodies to peptides not currently used for rheumatoid arthritis (RA) diagnosis helped identify patients with untreated early disease that conventional biomarkers missed, researchers said. Almost ...

We were always taught in medical school to talk to the patient, examine the patient. If these things are done correctly, a diagnosis to fit the patient’s complaints should follow. Laboratory testing ...

Please provide your email address to receive an email when new articles are posted on . “In recent years, several studies suggested that RA with positive [rheumatoid factor (RF)] and/or ...

In the initial EXXELERATE trial comparing the efficacy of CIMZIA and adalimumab, the primary endpoints of superiority were not met. In the post hoc analysis, efficacy outcomes in CIMZIA and adalimumab ...

A 4-biomarker panel can help ensure rheumatoid arthritis (RA) is accurately diagnosed, according to study results published in Arthritis Research & Therapy. A 4-biomarker panel can help ensure ...

NEW YORK (Reuters Health) - Smoking is a risk factor for rheumatoid arthritis (RA), a new analysis of 16 studies confirms. The effect is especially strong in men and heavy smokers, the researchers ...

ATLANTA, Nov. 11, 2023 /PRNewswire/ -- UCB, a global biopharmaceutical company, will present a post hoc analysis of the EXXELERATE trial examining the efficacy of CIMZIA ® (certolizumab pegol) and ...